Abstract:Following the publication of this article, a concerned reader drew to the Editor's attention that, for the Transwell migration assay experiments shown in Fig. 5B on p. 70, an unexpected area of similarity was identified in terms of the cellular data comparing the 'Control' and 'Inhibitor + si‐SCOS5' data panels, where the results from differently performed experiments were intended to have been shown, although the areas immediately surrounding this area featured comparatively different distributions of cells. In addition, the western blots in this article were presented with atypical, unusually shaped and possibly anomalous protein bands in many cases. After having conducted an internal investigation, the Editor of Oncology Letters has reached the conclusion that the potentially anomalous data in this paper were unlikely to have arisen by coincidence. Therefore, on the grounds of a lack of confidence in the integrity of these data, the Editor has decided that the article should be retracted from the publication. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused, and thanks the concerned reader for drawing this matter to our attention. [Oncology Letters 16: 65‐72, 2018; DOI: 10.3892/ol.2018.8645]

[Retracted] The oncogenic roles of 27‐hydroxycholesterol in glioblastoma

[Retracted] Effects of Grb2‐associated binding protein 2‐specific siRNA on the migration and invasion of MG‐63 osteosarcoma cells

[Retracted] hsa‐miR‐212 modulates the radiosensitivity of glioma cells by targeting BRCA1

[Retracted] AdipoR1‐mediated miR‐3908 inhibits glioblastoma tumorigenicity through downregulation of STAT2 associated with the AMPK/SIRT1 pathway

[Retracted] Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli‐1 degradation via the ubiquitin‐proteasome pathway

[Retracted] SOX2 knockdown inhibits the migration and invasion of basal cell carcinoma cells by targeting the SRPK1‐mediated PI3K/AKT signaling pathway

[Retracted] miR‐17‐5p promotes the growth of osteosarcoma in a BRCC2‐dependent mechanism

[Retracted] SRC‐like adaptor protein negatively regulates Wnt signaling in intrahepatic cholangiocarcinoma

[Retracted] Serum miR‐338‐5p has potential for use as a tumor marker for retinoblastoma

[Retracted] Long non‐coding RNA Igf2as controls hepatocellular carcinoma progression through the ERK/MAPK signaling pathway

[Retracted] SET and MYND domain‐containing protein 3 is overexpressed in human glioma and contributes to tumorigenicity

[Retracted] Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy

[Retracted] Schisandrin B inhibits epithelial‐mesenchymal transition and stemness of large‐cell lung cancer cells and tumorigenesis in xenografts via inhibiting the NF‐κB and p38 MAPK signaling pathways

[Retracted] MicroRNA‑505 is downregulated in human osteosarcoma and regulates cell proliferation, migration and invasion

[Retracted] Effect of RhoC on the epithelial‐mesenchymal transition process induced by TGF‐β1 in lung adenocarcinoma cells

[Retracted] miR‐885‐5p upregulation promotes colorectal cancer cell proliferation and migration by targeting suppressor of cytokine signaling

[Retracted] miR‐34a is downregulated in human osteosarcoma stem‐like cells and promotes invasion, tumorigenic ability and self‐renewal capacity

[Retracted] MicroRNA‐140 represses glioma growth and metastasis by directly targeting ADAM9

[Retracted] DNA methyltransferase 3b silencing affects locus‐specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC‐7721 and BEL‐7402 cells

[Retracted] Tissue‐specific transplantation antigen P35B functions as an oncogene and is regulated by microRNA‐125a‐5p in lung cancer

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells